1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Brighten Optix Corporation

Brighten Optix Corporation

6747.TWO
Brighten Optix CorporationTW flagTaipei Exchange
199.00
TWD
-0.50
- -
5.41BMarket Cap
Brighten Optix Corporation
6747.TWO
(Taipei Exchange)

Recent

price

199.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
18.69
19.3
20.5
21.18
21.87
23.78
27.36
27.47
28.2
28.34
Revenue per Share
- -
4.8
3.23
3.74
5
5.05
8.9
9.39
7.32
5.51
2.51
Basic EPS, GAAP
- -
0.55
3.13
6.52
5.7
5.9
4.96
7.15
5.86
6.13
6.55
Free Cash Flow per Basic Share
- -
- -
- -
2.9
2.47
4.04
4.8
7.72
8.09
4.78
- -
Dividend per Share
- -
17.15
17.95
19.56
20.37
19.49
22.27
24.93
23.11
29.59
21.25
Book Value per Share
- -
17.91
19.84
22.34
30.56
29.34
43.7
45.31
46.7
51.18
41.8
Tangible Book Value per Share
- -
18
18
20
23
25
27
27
27
27
27
Basic Weighted Avg Shares
- -
336
347
403
488
541
645
744
747
767
765
Sales/Revenue/Turnover
- -
31.42
22.25
19.79
26.28
27.78
35.28
35.32
27.79
18.22
12.63
Operating Margin (%)
- -
11
28
34
43
42
39
41
52
59
65
Depreciation Expense
- -
86
58
74
115
125
241
256
199
150
68
Net Income, GAAP
- -
20.84
16.61
18.33
12.94
12.59
19.39
15.11
17.61
16.74
2.79
Effective Tax Rate (%)
- -
25.7
16.73
18.27
23.61
23.11
37.41
34.33
26.66
19.53
8.85
Profit Margin (%)
73
74
74
143
356
390
677
692
585
783
437
Working Capital
74
77
57
33
32
23
16
14
27
19
43
LT Debt
241
326
360
443
708
728
1,186
1,241
1,278
1,415
1,157
Total Equity
- -
20.24
12.26
11.72
17.14
17.19
18.2
17.57
13.07
8.38
7.17
Return on Invested Capital (%)
- -
22.95
12.48
15.77
23.84
24.57
42.33
38.57
29.4
20.29
9.69
Return on Capital (%)
- -
32.16
18.4
20.8
27
26.27
44.43
39.87
30.49
20.9
9.95
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
10
9
9
LT Borrowings
- -
- -
- -
LT Finance Leases
17
15
43
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27
27
27
Market Capitalization
3,842
5,250
5,253

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
963
643
712
Cash, Cash Equivalents & STI
696
422
461
Accounts Receivable, Net
129
99
140
Inventories
119
109
82
Total Current Liabilities
401
139
275
Payables & Accruals
- -
- -
- -
ST Debt
10
9
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
16.81%
10.65%
Free Cash Flow
- -
6.91%
4.69%
Net Income, GAAP
- -
12.09%
-24.82%
Sales/Revenue/Turnover
- -
9.68%
2.63%
Total Cash Common Dividend
- -
26.17%
-40.91%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
196
157
235
160
747
2024
190
167
229
180
767
2025
206
162
217
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1.98
1.25
3.35
- -
7.32
2024
1.82
1.2
1.88
- -
5.51
2025
1.43
-1.65
2.15
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8.09
2024
- -
- -
- -
- -
4.78
2025
- -
- -
- -
- -
- -
Similar Companies
Olympus Corporation (7733.T)
Quipt Home Medical Corp. (QIPT.TO)
Embla Medical hf. (OSSUY)
AVDR US LargeCap Leading ETF (AVDR)
Coloplast A/S (CLPBY)
Ambu A/S (AMBBY)
Business
Brighten Optix Corporation engages primarily in the research, development, manufacture, and sale of optical lenses and related products. Its core offerings include a wide range of optical lenses such as ophthalmic lenses, camera lenses, and specialty glass lenses for various applications. The company provides lens processing services and optical component assemblies, targeting industries including consumer electronics, medical devices, and precision optics sectors. Brighten Optix operates predominantly in Taiwan but services global markets through its distribution network. Founded in 1999 and headquartered in Taipei, Taiwan, the company focuses on innovation and precision manufacturing in the optics industry. In the past 1-2 years, Brighten Optix Corporation has expanded its product portfolio and enhanced its technological capabilities through strategic partnerships and new product launches, aiming to strengthen its market position in both the medical and industrial optics segments. The company has emphasized increasing its R&D investment to support advanced lens technologies, including high-index and blue-light-blocking lenses, catering to rising global demand for advanced eyewear solutions. Additionally, Brighten Optix has undertaken operational optimizations to improve supply chain efficiency and expand its regional presence within East Asia. The company operates primarily within the optical manufacturing and precision components industry, serving customers that include eyewear manufacturers, camera and electronics companies, and medical device producers. Brighten Optix also manages several subsidiaries that support its manufacturing and distribution efforts, enhancing its capabilities in optical innovation and market reach. With a commitment to quality and technological advancement, Brighten Optix remains a notable player in the optics industry landscape, providing comprehensive optical solutions across diverse applications.